Medtronic acquires a trailblaizing surgical robotics company

| By | Life Sciences, Medical Devices, Medical Equipment

Medtronic, a global leader in medical technology, and Mazor Robotics, a pioneer in the field of robotic guidance systems, announced the companies have entered into a definitive merger agreement under which Medtronic will acquire Mazor Robotics.

This transaction builds on a relationship originated in May 2016 under a multi-phased strategic and equity investment agreement between Medtronic and Mazor. In August 2017, Medtronic expanded the partnership to become the exclusive worldwide distributor of the Mazor X system, leading to the successful installation of more than 80 Mazor X systems since launch.

Medtronic’s acquisition of Mazor strengthens Medtronic’s position as a global leader in enabling technologies for spine surgery, and drives Mazor Robotics’ vision to bring its core technology to the forefront of the global market. Mazor’s proprietary core platform technology, including the Mazor X Robotic Guidance System, and the Renaissance Surgical-Guidance System, are transforming spinal surgery from freehand procedures to accurate, state-of-the-art, guided procedures.

By combining Medtronic’s market-leading spine implants, navigation, and intra-operative imaging technology with Mazor’s robotic-assisted surgery (RAS) systems, Medtronic intends to offer a fully-integrated procedural solution for surgical planning, execution and confirmation.

Headquartered in Dublin (Ireland) with operational headquarters in Minnesota (USA), Medtronic is among the world’s largest medical technology, services and solutions companies.

Founded in 2001, Mazor, an Israeli medical device company and manufacturer of a robotic guidance system for spine surgery. In 2011, the company introduced the Renaissance system and in 2016 launched the next generation Mazor X system. Mazor Robotics US headquarters are located in Orlando, Florida.

SOURCE: medtronic
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.